Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
MSAC was delisted on the 17th of February, 2023.
54 hedge funds and large institutions have $104M invested in Medicus Sciences Acquisition Corp. Class A Ordinary Share in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 6 closing their positions.
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
10% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 10
4% more capital invested
Capital invested by funds: $99.4M → $104M (+$4.12M)
0% more funds holding
Funds holding: 54 → 54 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCL
Glazer Capital LLC
New York
|
+$4.65M |
| 2 |
DMKJ
David M. Knott Jr
|
+$1.96M |
| 3 |
CF
Cantor Fitzgerald
New York
|
+$967K |
| 4 |
Goldman Sachs
New York
|
+$721K |
| 5 |
SIA
Schechter Investment Advisors
Birmingham,
Michigan
|
+$526K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAA
Affinity Asset Advisors
New York
|
-$2.93M |
| 2 |
PCM
Prelude Capital Management
New York
|
-$1.01M |
| 3 |
CIM
Cowen Investment Management
New York
|
-$978K |
| 4 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
-$803K |
| 5 |
SMA
Sage Mountain Advisors
Atlanta,
Georgia
|
-$697K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
51
Tower Research Capital (TRC)
New York
| $17K | -$108 | -11 | -0.6% |
|
52
UBS Group
Zurich,
Switzerland
| $1K | -$3.03K | -309 | -84% |
|
53
JP Morgan Chase
New York
| $1K | – | – | – |
|
54
Bank of Montreal
Toronto,
Ontario, Canada
| $246 | – | – | – |
|
|
AAA
55
Affinity Asset Advisors
New York
| – | -$2.93M | -300,000 | Closed |
|
|
SCM
56
Silverarc Capital Management
Boston,
Massachusetts
| – | -$1.28K | -131,151 | Closed |
|
|
PCM
57
Prelude Capital Management
New York
| – | -$1.01M | -103,600 | Closed |
|
|
CIM
58
Cowen Investment Management
New York
| – | -$978K | -100,000 | Closed |
|
|
BCM
59
Beryl Capital Management
Redondo Beach,
California
| – | -$803K | -82,131 | Closed |
|
|
ICMH
60
Integrity Capital Management (HK)
Central,
Hong Kong
| – | -$97K | -9,894 | Closed |
|
MSAC Hedge Fund Activity: Q2 2022 in Review
54 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) for Q2 2022, worth a combined $104M — up 4.1% from $99.4M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new MSAC positions and 6 closed out — a net gain of 1 holder — while 11 added to existing stakes and 10 trimmed.
The largest buyer was Glazer Capital LLC, adding an estimated $4.65M. The largest seller was Affinity Asset Advisors, exiting entirely with an estimated $2.93M sold.
- 54 institutional investors held Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $104M of Medicus Sciences Acquisition Corp. Class A Ordinary Share stock for Q2 2022, up 4.1% quarter-over-quarter.
- 7 funds opened new Medicus Sciences Acquisition Corp. Class A Ordinary Share positions in Q2 2022 and 6 closed out, a net change of +1 holder.
- The largest Medicus Sciences Acquisition Corp. Class A Ordinary Share buyer in Q2 2022 was Glazer Capital LLC, an estimated $4.65M added.
- The largest Medicus Sciences Acquisition Corp. Class A Ordinary Share seller in Q2 2022 was Affinity Asset Advisors, an estimated $2.93M sold.
Based on aggregated 13F filings for Q2 2022.